clinical medicine

3,770 projects

HEIndividual fellowship2024–2026Spain

ChroMet · Elucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate.

HEIndividual fellowship2024–2027Austria

immunoMet · Deciphering immune evasion mechanisms of metastatic cancer cells using CRISPRa-inducible reporters

HEIndividual fellowship2024–2026Finland

NeuroCure · Novel nanosized GDNF mimetics for the treatment of Parkinson’s disease: focus onto non-dopaminergic features

HEIndividual fellowship2024–2026Luxembourg

INCEPTOR · Investigate the mode of action ofInvestigate the mode of action of beta-carboline derivative Harmine on increasing MHC-I expression and potentiating the Immune Checkpoint Blockade cancer immunotherapy

HEIndividual fellowship2024–2025Belgium

ORIBAR · Defining the origin of Barrett’s oesophagus by exploring a submucosal gland stem cell model

HEIndividual fellowship2024–2025Finland

TEATIME · Regulation of early colorectal cancer tumorigenesis by nutrient signalling of intestinal stem cells and their tissue environment

HEIndividual fellowship2024–2026Spain

SoMoWalk · Communicating walking movement through sonification.

3 partners · 2 countries

HEIndividual fellowship2024–2026Germany

PCNE · Plasticity of nuclear cycling in response to the environment

HEDoctoral network2024–2028Netherlands

EASYLI · EASY LISTENING: Optimizing the consequences of effortful listening in occupational settings

15 partners · 7 countries

HEDoctoral network2024–2028Netherlands

PRESSURE · Preventing Therapy Resistance in Esophageal Cancer Using Advanced Models and Molecular Signatures

21 partners · 9 countries

HEDoctoral network2024–2027Denmark

CLEAR · “CLEAR”: Cell Envelope Antibacterials

15 partners · 10 countries

HEDoctoral network2024–2028Italy

MetacMed · Acoustic and mechanical metamaterials for biomedical and energy harvesting applications

14 partners · 6 countries

HEIndividual fellowship2024–2026Spain

Co-CaReD · In-cell Redox Catalysis by Co(III) Metallodrugs as New Tools for Cancer Treatments

HEDoctoral network2024–2028Netherlands

MIRACLE · Multilevel inflammatory regulation in cardiometabolic disease

17 partners · 9 countries

HEIndividual fellowship2024–2027Italy

RISEN · Hip at what cost? How the human pelvis adapted to bipedalism and childbirth

4 partners · 3 countries

HEIndividual fellowship2024–2026Sweden

BiorthoCat-Immuno · Biorthogonal Catalytic Scaffold for in situ Personalized Cancer Chemo-Immunotherapy

HEIndividual fellowship2024–2026Germany

LivAdapt · Transcriptional adaptation during vertebrate development at the single-cell level

HEIndividual fellowship2024–2026Germany

sc-LAB2FATE · Revealing plasticity of developmental cell fate decisions by single-cell RNA labelling

HEIndividual fellowship2024–2026Spain

OvaCTool · Personalized medicine in ovarian cancer: Design and development of a tool for response prediction to targeted platinated nanocarrier-based treatments

HEIndividual fellowship2024–2025Italy

EDISENS · An Edible Microelectrofluidic Biosensor for Gastric Enzyme Quantification

HEIndividual fellowship2024–2026Spain

PLASMOSTEMFATE · In situ growth of thermoplasmonic nanoparticles in microfluidic platforms for modifying stem cell fate

2 partners · 2 countries

HEIndividual fellowship2024–2026Spain

WAC-mTOR-OC · Targeting R2TP/TTT/WAC/mTOR complex in ovarian cancer.

HEIndividual fellowship2024–2026Netherlands

PROPHOTOM · Protein Phototermal Optomechanical Analyzer

HEIndividual fellowship2024–2027Spain

AtheroGLP1 · Unmasking the molecular mechanisms mediating the antiatherogenic effects of GLP-1RAs

2 partners · 2 countries